{"transactions":[{"id":1194914,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":81674,"kind":"person","name":"Cote Jennifer","position":1,"cik":"0001960481","reported_name":"Cote Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-21T20:50:40.000Z","date":"2025-03-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":5687,"price":0.6886,"value":3916.0682,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit (\"RSU\") awards previously granted to the Reporting Person that vested in part on March 19, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) 8,964 RSUs that will vest on December 29, 2025, (b) 23,867 RSUs that will vest in two equal installments on March 19, 2026 and 2027, (c) 35,800 RSUs with performance based vesting conditions tied to achievements by the Company of certain performance criteria, (d) 25,862 RSUs with performance based vesting conditions tied to relative total shareholder return and (e) 64,526 shares of common stock (which includes 4,496 shares acquired on December 31, 2024 under the Issuer's Employee Stock Purchase Plan) beneficially owned by the Reporting Person."}],"balance_after":159019,"source":{"system":"sec-edgar","filing":"0001104659-25-026705","document":"tm259984-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000110465925026705/tm259984-2_4seq1.xml","form_type":"4"}},{"id":1319981,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":81674,"kind":"person","name":"Cote Jennifer","position":1,"cik":"0001960481","reported_name":"Cote Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-31T21:01:16.000Z","date":"2024-12-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":3797,"price":1.98,"value":7518.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit (\"RSU\") awards previously granted to the Reporting Person that vested in part on December 29, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) 8,964 RSUs that will vest on December 29, 2025, (b) 35,800 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (c) 35,800 RSUs with performance based vesting conditions tied to achievements by the Company of certain performance criteria, (d) 25,862 RSUs with performance based vesting conditions tied to relative total shareholder return and (e) 53,784 shares of common stock beneficially owned by the Reporting Person."}],"balance_after":160210,"source":{"system":"sec-edgar","filing":"0000921895-24-003051","document":"form412799001cot_12312024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000092189524003051/form412799001cot_12312024.xml","form_type":"4"}},{"id":1319980,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":81674,"kind":"person","name":"Cote Jennifer","position":1,"cik":"0001960481","reported_name":"Cote Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-31T21:01:16.000Z","date":"2024-12-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":4731,"price":1.98,"value":9367.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit (\"RSU\") awards previously granted to the Reporting Person that vested in part on December 29, 2024."}],"balance_after":164007,"source":{"system":"sec-edgar","filing":"0000921895-24-003051","document":"form412799001cot_12312024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000092189524003051/form412799001cot_12312024.xml","form_type":"4"}},{"id":1589648,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":81674,"kind":"person","name":"Cote Jennifer","position":1,"cik":"0001960481","reported_name":"Cote Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-07T21:04:04.000Z","date":"2024-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":9920,"price":4.11,"value":40771.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Company solely to cover tax obligations upon the vesting of 29,880 restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes (a) the awards described in footnotes (2) and (3) above, (b) 17,928 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (c) 11,171 RSUs that will vest on December 29, 2024, (d) 25,862 RSUs with performance based vesting conditions tied to relative total shareholder return and (e) 42,177 shares of common stock beneficially owned by the Reporting Person."}],"balance_after":168738,"source":{"system":"sec-edgar","filing":"0001193805-24-000334","document":"e619343_4-cote.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000119380524000334/e619343_4-cote.xml","form_type":"4"}},{"id":1589647,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":81674,"kind":"person","name":"Cote Jennifer","position":1,"cik":"0001960481","reported_name":"Cote Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-07T21:04:04.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":35800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The number of RSUs represents the target number of RSUs that may be earned based on achievement by the Company of certain performance criteria. The actual number of RSUs awarded may vary between 0% and 150% of the target, depending on the Company's performance. The performance period will end on December 31, 2026."}],"balance_after":178658,"source":{"system":"sec-edgar","filing":"0001193805-24-000334","document":"e619343_4-cote.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000119380524000334/e619343_4-cote.xml","form_type":"4"}},{"id":1589646,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":81674,"kind":"person","name":"Cote Jennifer","position":1,"cik":"0001960481","reported_name":"Cote Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-07T21:04:04.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":35800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of RSUs that will vest in three equal installments on March 19, 2025, 2026, and 2027."}],"balance_after":142858,"source":{"system":"sec-edgar","filing":"0001193805-24-000334","document":"e619343_4-cote.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000119380524000334/e619343_4-cote.xml","form_type":"4"}},{"id":1693669,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":81674,"kind":"person","name":"Cote Jennifer","position":1,"cik":"0001960481","reported_name":"Cote Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T22:17:24.000Z","date":"2023-12-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":2631,"price":5.35,"value":14075.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit awards previously granted to the reporting person that vested in part on December 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) 17,928 restricted stock units that will vest in two equal installments on December 29, 2024 and 2025, (b) 11,171 restricted stock units that will vest on December 29, 2024, (c) 25,862 restricted stock units with performance based vesting conditions tied to relative total shareholder return, (d) 29,880 restricted stock units that will vest on March 6, 2024 and (e) 22,217 shares of common stock beneficially owned by the Reporting Person."}],"balance_after":107058,"source":{"system":"sec-edgar","filing":"0000921895-24-000042","document":"form412799001cot_01032024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000092189524000042/form412799001cot_01032024.xml","form_type":"4"}},{"id":1693668,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":81674,"kind":"person","name":"Cote Jennifer","position":1,"cik":"0001960481","reported_name":"Cote Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T22:17:24.000Z","date":"2023-12-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":3279,"price":5.35,"value":17542.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit awards previously granted to the reporting person that vested in part on December 29, 2023."}],"balance_after":109689,"source":{"system":"sec-edgar","filing":"0000921895-24-000042","document":"form412799001cot_01032024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000092189524000042/form412799001cot_01032024.xml","form_type":"4"}},{"id":1963817,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":81674,"kind":"person","name":"Cote Jennifer","position":1,"cik":"0001960481","reported_name":"Cote Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2023-03-08T22:01:14.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":29880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents an award of 29,880 restricted stock units that will fully vest on March 6, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes (a) the shares and awards described in footnote (4) above and (b) the award described in footnote (5) above."}],"balance_after":112968,"source":{"system":"sec-edgar","filing":"0000921895-23-000667","document":"form412799cot_03082023.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000092189523000667/form412799cot_03082023.xml","form_type":"4"}},{"id":1963816,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":81674,"kind":"person","name":"Cote Jennifer","position":1,"cik":"0001960481","reported_name":"Cote Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2023-03-08T22:01:14.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":25862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an award of 25,862 restricted stock units with performance based vesting conditions. These restricted stock units will vest upon the achievement of a relative total shareholder return of the Issuer's common stock during the period from March 1, 2023 to the earlier of (i) December 31, 2025, and (ii) the date of a change of control (the \"Measurement Period\"), measured relative to the Russell 2000 index and based on the 20-day trading average beginning on the first day of the Measurement Period and ending on the last day of the Measurement Period, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes (a) the shares and awards described in footnote (2) above and (b) the award described in footnote (3) above."}],"balance_after":83088,"source":{"system":"sec-edgar","filing":"0000921895-23-000667","document":"form412799cot_03082023.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000092189523000667/form412799cot_03082023.xml","form_type":"4"}},{"id":1963815,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":81674,"kind":"person","name":"Cote Jennifer","position":1,"cik":"0001960481","reported_name":"Cote Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2023-03-08T22:01:14.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":26892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 26,892 restricted stock units that will vest in three equal installments on December 29, 2023, 2024 and 2025, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) the award described in footnote (1) above, (b) 22,342 restricted stock units that will vest in two equal installments on December 29, 2023 and 2024 and (c) 7,992 shares of common stock beneficially owned by the Reporting Person."}],"balance_after":57226,"source":{"system":"sec-edgar","filing":"0000921895-23-000667","document":"form412799cot_03082023.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000092189523000667/form412799cot_03082023.xml","form_type":"4"}}]}